Your institution may have access to this item. Find your institution then sign in to continue.
Title
Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.
Authors
Schneeweiss, Sebastian; Doherty, Mike; Zhu, Shao; Funch, Donnie; Schlienger, Raymond G; Fernandez-Vidaurre, Carlos; Seeger, John D
Abstract
A potential risk of lymphoma associated with the use of topical calcineurin inhibitors is debated. We assessed the risk of lymphoma among patients treated with topical pimecrolimus, tacrolimus or corticosteroids.